QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
LON:SIS

Science in Sport (SIS) Share Price, News & Analysis

GBX 15.66
-0.09 (-0.57%)
(As of 03:37 PM ET)
Today's Range
15.50
15.98
50-Day Range
15.10
17.75
52-Week Range
9
18
Volume
111,056 shs
Average Volume
332,514 shs
Market Capitalization
£28.22 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
SIS stock logo

About Science in Sport Stock (LON:SIS)

Science in Sport plc, together with its subsidiaries, develops, manufactures, and markets sports nutrition products for professional athletes, sports and fitness enthusiasts, and the active lifestyle community in the United Kingdom, rest of Europe, the United States, and internationally. It operates through Science in Sport and PhD Nutrition segments. The company offers energy bars, gels, powders, and shots; hydration products, such as gels, tablets, and powders; recovery products; vitamins and supplements; diet whey; high protein and low sugar foods, bars, and snacks; high protein and low sugar plant-based complete meal solution; and Reset, a night time formula. It sells its products under the PhD Nutrition and Science in Sport brand names through retail distribution, including supermarkets and high street chains, and specialist sports retailers; grocers; convenience and discount retailers; and international wholesalers, retailers, and distributors, as well as phd.com and scienceinsport.com digital platforms, and third-party online sites. Science in Sport plc was founded in 1992 and is headquartered in London, the United Kingdom.

SIS Stock Price History

SIS Stock News Headlines

Tiny Biotech Stock Wins $75 Billion Patent
A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.
Tiny Biotech Stock Wins $75 Billion Patent
A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.
See More Headlines
Receive SIS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Science in Sport and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
9/16/2020
Today
4/19/2024

Industry, Sector and Symbol

Industry
Packaged Foods
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
320
Year Founded
N/A

Profitability

Net Income
£-7,070,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
£65.93 million
Cash Flow
GBX (2.20) per share
Book Value
GBX 22 per share

Miscellaneous

Free Float
N/A
Market Cap
£28.79 million
Optionable
Not Optionable
Beta
0.51
Elon Musk's Next Move Cover

Wondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.

Get This Free Report

Key Executives

  • Mr. Daniel Malachy Lampard (Age 44)
    CFO, Secretary & Executive Director
    Comp: $240k
  • Mr. Stephen Nigel Moon MBA (Age 67)
    Executive Director (Garden Leave)
    Comp: $398k
  • Mr. Daniel Patrick Wright (Age 52)
    Executive Chairman
  • Ms. Bernadette Ude-Wetherell
    Chief People Officer
  • Mr. Andy Bott
    Chief Commercial Officer

SIS Stock Analysis - Frequently Asked Questions

How have SIS shares performed in 2024?

Science in Sport's stock was trading at GBX 11.75 at the beginning of 2024. Since then, SIS shares have increased by 33.3% and is now trading at GBX 15.66.
View the best growth stocks for 2024 here
.

How were Science in Sport's earnings last quarter?

Science in Sport plc (LON:SIS) released its quarterly earnings results on Wednesday, September, 16th. The company reported ($1.80) earnings per share for the quarter. Science in Sport had a negative trailing twelve-month return on equity of 18.91% and a negative net margin of 10.72%.

What other stocks do shareholders of Science in Sport own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Science in Sport investors own include Cidara Therapeutics (CDTX), Carnival Co. & (CCL), Bellway (BWY), British American Tobacco (BTI), boohoo group (BOO), B&M European Value Retail (BME), Balfour Beatty (BBY), Alibaba Group (BABA), Advanced Oncotherapy (AVO) and ASOS (ASC).

How do I buy shares of Science in Sport?

Shares of SIS stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

This page (LON:SIS) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners